Related Experiment Video
Updated: Jun 15, 2026
08:03
Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation
Juan Wang1, Liying Huang, Jian Li
1The State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China.
Plos One
|March 12, 2010
Summary
Artemisinin targets mitochondria to fight malaria. Its peroxide bridge is key, causing reactive oxygen species (ROS) in parasite mitochondria but not human cells, explaining its specific action.
Area of Science:
- Biochemistry
- Parasitology
- Drug Discovery
Background:
- The antimalarial artemisinin's mechanism of action has been debated.
- Previous studies implicated mitochondria in artemisinin's effects.
Purpose of the Study:
- To elucidate the direct mitochondrial target and specificity of artemisinin's antimalarial action.
- To investigate the role of the peroxide bridge and reactive oxygen species (ROS) in artemisinin's efficacy.
Main Methods:
- Comparative studies using yeast and Plasmodium falciparum (malaria parasite) models.
- Assays on isolated mitochondria (malarial and mammalian) to measure membrane potential and ROS production.
- Experiments with artemisinin analogues and other antimalarial endoperoxides.
- Investigation of mitochondrial electron transport chain (ETC) interference.
Main Results:
- Artemisinin directly inhibits malarial mitochondria, similar to its effect in yeast.
- The peroxide bridge is crucial for activity; deoxyartemisinin lacks effect.
- Artemisinin induces rapid ROS production in malarial but not mammalian mitochondria.
- Mitochondrial ETC interference alters parasite sensitivity and mitigates ROS production.
Conclusions:
- Mitochondria are a direct and critical target for artemisinin's antimalarial activity.
- Species-specific differences in mitochondrial activation explain artemisinin's targeted action.
- Artemisinin's specificity arises from its unique activation mechanism within parasite mitochondria.
More Related Videos
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:30The Electron Transport Chain
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...